Rapid relief
may start in 3 days
ZURZUVAE® (zuranolone) is a 14-day oral treatment for
women with postpartum depression. ZURZUVAE was studied
in a clinical trial comparing it to placebo.
In a clinical study, ZURZUVAE
provided a fast way to feel symptom relief
Rapid relief
Women experienced PPD symptom improvement at Day 15 and as early as Day 3.
Results that lasted
Women continued to feel relief around 4 weeks after they finished taking ZURZUVAE.
ZURZUVAE 50 mg was studied in women with PPD whose symptoms started in the third trimester or within 4 weeks of delivery in a 6-week trial. During the trial, patients took either ZURZUVAE or placebo for 14 days, and were followed up for another 4 weeks. Significantly greater PPD symptom improvement was demonstrated at Day 3, Day 15 (the primary endpoint), and Day 45 compared to placebo, using a standard depression rating scale.
Talk to your healthcare provider about ZURZUVAE
Download the Conversation Starter
Get help starting the conversation.
If you have questions about available services and ZURZUVAE resources, you can call the
ZURZUVAE For You support line at
1-844-987-9882.